Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login


Sodium thiosulfate lowers hearing loss risk in cisplatin-treated children

Research into hearing loss in children treated with cisplatin-based chemotherapy has shown promising results, with a 48% lower risk following use of sodium thiosulfate.

Sodium thiosulfate reduces the risk of hearing loss owing to cisplatin-based chemotherapy in children with hepatoblastoma, a study published in the New England Journal of Medicine (21 June 2018) has shown[1].

Researchers randomly assigned 109 children (median age 13 months) with standard-risk hepatoblastoma to either cisplatin alone or cisplatin with an infusion of sodium thiosulfate six hours later. All patients received four pre-operative and two postoperative courses.

At median follow-up of 52 months, the risk of hearing loss was 48% lower in the sodium thiosulfate group. Hearing loss, assessed according to the Brock grade, of grade 1 or higher occurred in 63% of those who did not receive sodium thiosulfate, compared with 33% of those who did.

Rates of three-year event-free and overall survival were similar between the two groups.

The researchers explained that cisplatin-based therapy is very effective in hepatoblastoma but frequently causes hearing loss. This can be particularly damaging to development in younger children.

“We found that the delayed administration of sodium thiosulfate resulted in a significantly lower incidence of cisplatin-induced hearing loss, with no evidence of tumour protection,” they concluded.

Sodium thiosulfate is not yet licensed in the EU but has received a breakthrough therapy designation from the US Food and Drug Administration.

Citation: Clinical Pharmacist DOI: 10.1211/CP.2018.20205192

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Patient Care in Community Practice

    Patient Care in Community Practice

    Patient Care in Community Practice is a unique, practical guide for healthcare professionals or carers. Covers a range of non-medicinal products suitable for use at home.

    £22.00Buy now
  • Pharmacy OSCEs

    Pharmacy OSCEs

    The only pharmacy-specific OSCE revision guide. This easy-to-use book covers the key competencies that will be tested in your exams.

    £25.00Buy now
  • Drugs and the Liver

    Drugs and the Liver

    Drugs and the Liver assists practitioners in making pragmatic choices for their patients. It enables you to assess liver function and covers the principles of drug use in liver disease.

    £38.00Buy now
  • Physicochemical Principles of Pharmacy

    Physicochemical Principles of Pharmacy

    This established textbook covers every aspect of drug properties from the design of dosage forms to their delivery by all routes to sites of action in the body.

    £48.00Buy now
  • Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics covers all aspects of drug use in renal failure. Shows the role of the pharmacist in patient care for chronic kidney disease.

    £38.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Deaf child using hearing aid

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.